Arch Therapeutics Announces Closing of $6.9 Million Private Placement
18 févr. 2021 07h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, today...
Arch Therapeutics to Present at the H.C. Wainwright BioConnect Conference, January 11 - 14, 2021
05 janv. 2021 07h55 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel self-assembling wound care and biosurgical devices, announced...
Arch Therapeutics Announces Distribution Agreement with Buffalo Supply, Inc.
04 janv. 2021 07h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel self-assembling wound care and biosurgical devices, announced...
Arch Therapeutics, Inc. to Present at the Virtual Investor KOL Roundtable
22 oct. 2020 07h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) (“Arch” or the “Company”), developer of novel liquid, gel and solid hemostatic and wound care devices, today...
Arch Therapeutics to Present at The LD 500 Virtual Conference on Tuesday, September 1 at 1 PM ET
26 août 2020 07h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Aug. 26, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices,...
SANUWAVE Continues to Increase Clinical Symposia Presence With SAWC Fall 2019
16 oct. 2019 09h00 HE
|
SANUWAVE Health, Inc.
Symposia and Posters Presenting Compelling Clinical Evidence in Treating Diabetic Foot Ulcers With dermaPACE®System SUWANEE, GA, Oct. 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE...
Arch Therapeutics to Provide Corporate Update at the H.C. Wainwright 21st Annual Global Investment Conference
03 sept. 2019 07h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices,...
Arch Therapeutics Announces Attendance at 2019 Symposium on Advanced Wound Care Conference (SAWC) and Release of a New AC5TM Topical Gel Video
24 avr. 2019 07h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., April 24, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of products for dermal science and biosurgical applications, today...
SANUWAVE Health, Inc. Announces a New Shock This Blog Regarding an Interview With Michael Stolarski, the Owner, President, and CEO of Premier Shockwave, Inc. and Premier Shockwave Wound Care, Inc.
27 déc. 2018 08h00 HE
|
SANUWAVE Health, Inc.
SUWANEE, GA, Dec. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) an emerging medical technology company focused on the development and commercialization of...
SANUWAVE Announces Exhibition at Fall SAWC 2018 Including a Poster and Three Presentations - Visit us at Booth #441
17 oct. 2018 08h00 HE
|
SANUWAVE Health, Inc.
SUWANEE, GA , Oct. 17, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the company will exhibit at SAWC (Symposium on Advanced Wound...